These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FXIII polymorphisms, fibrin clot structure and thrombotic risk. Kobbervig C; Williams E Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253 [TBL] [Abstract][Full Text] [Related]
4. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. von dem Borne PA; Cox LM; Bouma BN Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866 [TBL] [Abstract][Full Text] [Related]
5. Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity. Varin R; Mirshahi S; Mirshahi P; Kierzek G; Sebaoun D; Mishal Z; Vannier JP; Yvonne Borg J; Simoneau G; Soria C; Soria J Thromb Haemost; 2007 Jan; 97(1):27-31. PubMed ID: 17200767 [TBL] [Abstract][Full Text] [Related]
6. High dose factor VIIa improves clot structure and stability in a model of haemophilia B. Wolberg AS; Allen GA; Monroe DM; Hedner U; Roberts HR; Hoffman M Br J Haematol; 2005 Dec; 131(5):645-55. PubMed ID: 16351642 [TBL] [Abstract][Full Text] [Related]
7. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin. Kumar R; Béguin S; Hemker HC Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079 [TBL] [Abstract][Full Text] [Related]
8. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I. Terasawa F; Kani S; Hongo M; Okumura N Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498 [TBL] [Abstract][Full Text] [Related]
9. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban. Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382 [TBL] [Abstract][Full Text] [Related]
10. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis? Bouma BN; Mosnier LO Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302 [TBL] [Abstract][Full Text] [Related]
11. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment. Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149 [TBL] [Abstract][Full Text] [Related]
13. Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system. Ajjan RA; Standeven KF; Khanbhai M; Phoenix F; Gersh KC; Weisel JW; Kearney MT; Ariëns RA; Grant PJ Arterioscler Thromb Vasc Biol; 2009 May; 29(5):712-7. PubMed ID: 19286636 [TBL] [Abstract][Full Text] [Related]
14. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Schols SE; Lancé MD; Feijge MA; Damoiseaux J; Marcus MA; Hamulyák K; Ten Cate H; Heemskerk JW; van Pampus EC Thromb Haemost; 2010 Feb; 103(2):318-28. PubMed ID: 20024495 [TBL] [Abstract][Full Text] [Related]
15. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets. Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348 [TBL] [Abstract][Full Text] [Related]
16. [The TAFI system. The new role of fibrinolysis]. Dempfle CE Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767 [TBL] [Abstract][Full Text] [Related]